Which is why in all of the studies of people taking GLP-1 semaglutide, people regain weight very quickly after ceasing treatment
However, the study found that semaglutide also affects body fat distribution and adipocyte characteristics: semaglutide led to a reduction in adipocyte size and macrophage infiltration, an increase in molecular markers of adipocyte browning along with improved mitochondrial biogenesis, and a decrease in endoplasmic reticulum stress
WHAT KAISER REQUIRES FIRST Step Therapy Requirements Even in regions where Kaiser covers Zepbound, you must typically "fail" multiple other treatments first: Kaiser Northwest Example (Most Documented) To qualify for Zepbound coverage in Kaiser Northwest, you must demonstrate: [3] Kaiser Zepbound Coverage Criteria BMI 30 (obesity) OR BMI 27 with a comorbidity (hypertension, diabetes, high cholesterol) Age 18+ Following a structured diet and exercise program (documented, not just attested) Failed at least 2 prior weight loss medications : Phentermine Diethylpropion Qsymia (phentermine/topiramate) Contrave (naltrexone/bupropion) Tried semaglutide (Wegovy or Ozempic) for minimum 6 months and either: It was ineffective (didn't achieve target weight loss) Cannot tolerate due to allergy, serious side effects, or contraindication Continuation Requirements (To Keep Coverage) Initial approval typically for 12 months Must document at least 5% weight loss after starting tirzepatide to continue coverage Bariatric medicine chart review required before switching from semaglutide to Zepbound Kaiser's Internal "Medical Weight Management" Program Kaiser often requires patients to enroll in their internal weight management program before approving GLP-1s
PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first month of tirzepatide treatment
Heres what the science says: Respiratory Health: NAC reduced COPD flare-ups by 43.8% (NIH) Mental Wellbeing: Reduced compulsive behavior by 38.3% in 12 weeks (NIH)
